Replies to post #82414 on Amarantus Bioscience Holdings Inc (AMBS)

[retiredtech]

Given all the platforms that MANF might be applicable solutions for I believe the SP will be over $2.00 within 12 months time. I can see this stock skyrocketing on ever release of every study and trial. With 6 potential platforms my God I cannot even fathom the money involved. This would seen to be LARGER than all the bio-pharm's that currently exist, put together.

[Skeetz99]

There are no preconceived notions that a R/S is inevitable. A combination of a LymPro partnership (includes up front million dollar cash investments and maybe one MANF Orphan partnership ...(mininimum investment of $30-$40mm upfront) ....may be enough to get us there.

I highly doubt Gerald has disseminated his intentions to do a R/S to any one shareholder (via phone).

[Natural Treasures]

I agree current share price is a gift. I disagree we need a R/S to get to the NASDAQ. You announce some partnerships with up front money, we are there. The longer Big pharma waits the more this is worth.